A randomized placebo-controlled trial of d-cycloserine and exposure therapy for posttraumatic stress disorder

Journal of Psychiatric Research

Volumn 46, Issue 9, 2012, Pages 1184-1190

  Litz, Brett T ^a,b,c   Salters Pedneault, Kristalyn ^d   Steenkamp, Maria M ^b   Hermos, John A ^b,c   Bryant, Richard A ^e   Otto, Michael W ^f   Hofmann, Stefan G ^f  

^a National Center for PTSD   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EASTERN CONNECTICUT STATE UNIVERSITY   (United States)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f BOSTON UNIVERSITY   (United States)

Author keywords

DCS; Exposure therapy; Imaginal; PTSD; Veterans

Indexed keywords

CYCLOSERINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXPOSURE; EXPOSURE THERAPY; HUMAN; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VETERAN;

EID: 84864395164     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.05.006     Document Type: Article

References (46)

1. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck depression inventory-II 1996, Psychological Corporation, San Antonio, TX.
2. Blake D.D., Weathers F.W., Nagy L.N., Kaloupek D.G., Klauminzer G., Charney D.S. A clinician rating scale for assessing current and lifetime PTSD: the CAPS-1. The Behavior Therapist 1990, 13:187-188.
3. Blanchard E.B., Jones-Alexander J., Buckley T.C., Forneris C.A. Psychometric properties of the PTSD checklist (PCL). Behaviour Research and Therapy 1996, 34:669-673.
4. Blechert J., Michael T., Vriends N., Margraf J., Wilhelm F.H. Fear conditioning in posttraumatic stress disorder: evidence of delayed extinction of autonomic, experiential, and behavioral responses. Behaviour Research and Therapy 2007, 45:2019-2033.
5. Bryant R.A., Moulds M.L., Guthrie R.M., Nixon R.D.V. The additive benefit of hypnosis and cognitive-behavioral therapy in treating acute stress disorder. Journal of Consulting and Clinical Psychology 2005, 73:334-340.
6. Daniels M.J., Hogan J.W. Missing data in longitudinal studies 2008, Chapman & Hall, New York.
7. Davis M., Ressler K., Rothbaum B.O., Richardson R. Effects of d-cycloserine on extinction: translation from preclinical to clinical work. Biological Psychiatry 2006, 60:369-375.
8. De Kleine R.A., Hendriks G.J., Kusters W.J.C., Broekman T., van Minnen A. A randomized placebo-controlled trial of d-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biological Psychiatry 2012, 71:962-968.
9. Dunlop W.P., Cortina J.M., Vaslow J.B., Burke M.J. Meta-analysis of experiments with matched groups or repeated measures designs. Psychological Methods 1996, 1:170-177.
10. Felmingham K.L., Bryant R.A. Gender differences in the maintenance of response to cognitive behavior therapy for posttraumatic stress disorder. Journal of Consulting and Clinical Psychology 2012, 80:196-200.
11. Foa E.B., Steketee G., Rothbaum B.O. Behavioral and cognitive conceptualizations of post-traumatic stress disorder. Behavior Therapy 1989, 20:155-176.
12. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV axis I disorder-patient edition (SCID-I/P) 1995, Biometrics Research Department, State Psychiatric Institute, New York.
13. Guastella A.J., Richardson R., Lovibond P.F., Rapee R.M., Gaston J.E., Mitchell P., et al. A randomized controlled trial of d-cycloserine enhancement of exposure therapy for social anxiety disorder. Biological Psychiatry 2008, 63:544-549.
14. Guthrie R.M., Bryant R.A. Extinction learning before trauma and subsequent posttraumatic stress. Psychosomatic Medicine 2006, 68:307-311.
15. Hedges L.V., Olkin I. Statistical methods for meta-analysis 1985, Academic Press, Orlando, FL.
16. Hofmann S.G. Enhancing exposure-based therapy from a translational research perspective. Behaviour Research and Therapy 2007, 45:1987-2001.
17. Hofmann S.G., Meuret A.E., Smits J.A., Simon N.M., Pollack M.H., Eisenmenger K., et al. Augmentation of exposure therapy with d-cycloserine for social anxiety disorder. Archives of General Psychiatry 2006, 63:298-304.
18. Hoge C.W., Castro C.A., Messer S.C., McGurk D., Cotting D.I., Koffman R.L. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. New England Journal of Medicine 2004, 351:13-22.
19. King L.A., King D.W., Vogt D.S., Knight J., Samper R. Deployment risk and resilience inventory: a collection of measures for studying deployment-related experiences of military personnel and veterans. Military Psychology 2006, 18:89-120.
20. Kushner M.G., Kim S.W., Donahue C., Thuras P., Adson D., Kotlyar M., et al. d-Cycloserine augmented exposure therapy for obsessive compulsive disorder. Biological Psychiatry 2007, 62:835-838.
21. Ledgerwood L., Richardson R., Cranney J. d-Cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. Behavioral Neuroscience 2004, 118:505-513.
22. Lee J.L., Milton A.L., Everitt B.J. Reconsolidation and extinction of conditioned fear: inhibition and potentiation. Journal of Neuroscience 2006, 26:10051-10056.
23. Milad M.R., Orr S.P., Lasko N.B., Chang Y., Rauch S.L., Pitman R.K. Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. Journal of Psychiatric Research 2008, 42:515-520.
24. Milad M.R., Pitman R.K., Ellis C.B., Gold A.L., Shin L.M., Lasko N.B., et al. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biological Psychiatry 2009, 66:1075-1082.
25. Milad M.R., Rauch S.L., Pitman R.K., Quirk G.J. Fear extinction in rats: implications for human brain imaging and anxiety disorders. Biological Psychology 2006, 73:61-71.
26. Monson C.M., Schnurr P.P., Resick P.A., Friedman M.J., Yinong Y.X., Stevens S.P. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. Journal of Consulting and Clinical Psychology 2006, 74:898-907.
27. Nader K., Hardt O. A single standard for memory: the case for memory reconsolidation. Nature Reviews Neuroscience 2009, 10:224-234.
28. Norberg M.M., Krystal J.H., Tolin D.F. A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry 2008, 63:1118-1126.
29. Otto M.W., Tolin D.F., Simon N.M., Pearlson G.D., Basden S., Meunier S.A., et al. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biological Psychiatry 2010, 67:365-370.
30. Przybyslawski J., Sara S.J. Reconsolidation of memory after its reactivation. Behavioural Brain Research 1997, 84:241-246.
31. Quirk G.J., Paré D., Richardson R., Herry C., Monfils M.H., Schiller D., et al. Erasing fear memories with extinction training. Journal of Neuroscience 2010, 30:14993-14997.
32. Raudenbush S.W., Bryk A.S., Congdon R.T. HLM 6 2005, Scientific Software International, Lincolnwood, IL.
33. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., et al. Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobics to facilitate extinction of fear. Archives of General Psychiatry 2004, 61:1136-1144.
34. Rothbaum B. Critical parameters for d-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder. American Journal of Psychiatry 2008, 165:293-296.
35. Royer S., Pare D. Bidirectional synaptic plasticity in intercalated amygdala neurons and the extinction of conditioned fear responses. Neuroscience 2002, 115:455-462.
36. Schiller D., Monfils M.H., Raio C.M., Johnson D.C., LeDoux J.E., Phelps E.A. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 2010, 463:49-54.
37. Schnurr P.P., Friedman M.J., Engel C.C., Foa E.B., Shea M.T., Chow B.K. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. Journal of the American Medical Association 2007, 297:820-830.
38. Seal K.H., Maguen S., Cohen B., Gima K.S., Metzler T.J., Ren L., et al. VA mental health service utilization in Iraq and Afghanistan veterans in the first year of receiving a new mental health diagnosis. Journal of Traumatic Stress 2010, 23:15-16.
39. Suzuki A., Josselyn S.A., Frankland P.W., Masushige S., Silva A.J., Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. Journal of Neuroscience 2004, 24:4787-4795.
40. Torras-Garcia M., Lelong J., Tronel S., Sara S.J. Reconsolidation after remembering an odor-reward association requires NMDA receptors. Learning & Memory 2005, 12:18-22.
41. Tronson N.C., Taylor J.R. Molecular mechanisms of memory consolidation. Nature Reviews Neuroscience 2007, 8:262-275.
42. Vasterling J.J., Proctor S.P., Friedman M.J., Hoge C.W., Heeren T., King L.A. PTSD symptom increases in Iraq-deployed soldiers: comparison with non-deployed soldiers and associations with baseline symptoms, deployment experiences, and postdeployment stress. Journal of Traumatic Stress 2010, 23:41-51.
43. Weathers F.W., Keane T.M., Davidson J.R. Clinician-administered PTSD scale: a review of the first ten years of research. Depression and Anxiety 2001, 13:132-158.
44. Weathers F.W., Litz B., Herman D.S., Huska J.A., Keane T.M. The PTSD checklist: reliability, validity, & diagnostic utility 1993, National Center for Posttraumatic Stress Disorder, Boston, MA.
45. Wilhelm S., Buhlmann U., Tolin D.F., Meunier S.A., Pearlson G.D., Reese H.E., et al. Augmentation of behavior therapy with d-cycloserine for obsessive-compulsive disorder. American Journal of Psychiatry 2008, 165:335-341.
46. Yamamoto S., Morinobu S., Fuchikami M., Kurata A., Kozuru T., Yamawaki S. Effects of single prolonged stress and d-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD. Neuropsychopharmacology 2008, 33:2108-2116.